Organic Letters
Letter
(11) Ireland, R. E.; Brown, F. R. J. Org. Chem. 1980, 45, 1868−1880.
(12) (a) Murai, T.; Asai, F. J. Am. Chem. Soc. 2007, 129, 780−781.
(b) Murai, T.; Ui, K.; Narengerile. J. Org. Chem. 2009, 74, 5703−5706.
(13) Reactions employing weaker bases, such as MOt-Bu and
MHMDS (M = Li, Na, K), generated inferior results possibly due to
incomplete deprotonation of the nitrile. Reactions using dimethyl-
thioformamide as the electrophile did not produce any desired
thiophene products, presumably because of its weaker electrophilicity.
(14) (a) Vilsmeier, A.; Haack, A. Ber. 1927, 60, 119−122. (b) Meth-
Cohn, O.; Stanforth, S. P. Comp. Org. Synth. 1991, 2, 777−794.
(15) For the synthesis and biological properties of thieno[3,2-d]
pyrimidines, see: (a) Varvounis, G.; Giannopoulos, T. Adv. Heterocycl.
Chem. 1996, 66, 193−283. (b) Ibrahim, Y. A.; Elwahy, A. H. M.;
Kadry, A. M. Adv. Heterocycl. Chem. 1996, 65, 235−281. (c) Nakazato,
A.; Okubo, T.; Nozawa, D.; Tamita, T.; Kennis, L. E. J. U.S. Pat. Appl.
2009, 7557111.
AUTHOR INFORMATION
■
Corresponding Authors
Present Address
†Small Molecule Process Chemistry, Genentech, Inc., 1 DNA
Way, South San Francisco, CA 94080.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
The authors would like to thank Mr. Leonard Hargiss for
collecting HRMS data as well as Drs. Matt Zhao and Lauren
Sirois (all from Lexicon Pharmaceuticals) for proofreading the
manuscript.
(16) (a) Miyaura, N.; Suzuki, A. Chem. Commun. 1979, 866−867.
(b) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457−2483.
(17) (a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett.
1975, 16, 4467−4470. (b) Chinchilla, R.; Naj
́
era, C. Chem. Rev. 2007,
107, 874−922.
REFERENCES
■
(1) (a) Sabnis, R. W.; Rangnekar, D. W.; Sonawane, N. D. J.
Heterocycl. Chem. 1999, 36, 333−345. (b) Paulmier, C. Sulf. Rep. 1996,
19, 215−284. (c) Litvinov, V. P.; Sharanin, Y. A.; Babichev, F. S. Sulf.
Rep. 1986, 6, 97−128. (d) Fiesselmann, H.; Schipprak, P. Chem. Ber.
1954, 87, 835−841. (e) Redman, A. M.; Johnson, J. S.; Dally, R.;
Swartz, S.; Wild, H.; Paulsen, H.; Caringal, Y.; Gunn, D.; Renick, J.;
Osterhout, M.; Kingery-Wood, J.; Smith, R. A.; Lee, W.; Dumas, J.;
Wilhelm, S. M.; Housley, T. J.; Bhargava, A.; Ranges, G. E.;
Shrikhande, A.; Young, D.; Bombara, M.; Scott, W. J. Bioorg. Med.
Chem. Lett. 2001, 11, 9−12. (f) Gommper, R.; Kutter, E. Angew.
Chem., Int. Ed. Engl. 1962, 1, 216.
(2) Gewald, K.; Schinke, E.; Bottcher, H. Chem. Ber. 1966, 99, 94−
̈
100.
(3) Knoevenagel, E. Ber. 1898, 31, 2596−2619.
(4) For the synthesis of 5-substituted 3-amino-2-cyanothiophenes,
see: (a) Ren, W.-Y.; Kambhampati, V. B. R.; Klein, R. S. J. Heterocycl.
Chem. 1986, 23, 1757−1763. (b) Thomae, D.; Kirsch, G.; Seck, P.
Synthesis 2007, 1027−1032. For the synthesis of 4-substituted 3-
aminothiophene-2-carboxylates, see: (c) Lisowski, V.; Leonce, S.;
Kraus-Berthier, L.; Sopkova-de Oliveira Santos, J.; Pierre, A.; Atassi,
G.; Caignard, D.-H.; Renard, P.; Rault, S. J. Med. Chem. 2004, 47,
1448−1464. (d) Belov, V. N.; Savchenko, A. I.; Sokolov, V. V.; Straub,
A.; de Meijere, A. Eur. J. Org. Chem. 2003, 3, 551−561. (e) Kirsch, G.;
Cagniant, D.; Cagniant, P. J. Heterocycl. Chem. 1982, 19, 443−445.
(5) (a) Babu, Y. S.; Chand, P.; Wu, M.; Kotian, P. L.; Kumar, V. S.;
Lin, T.-H.; El-Kattan, Y.; Ghosh, A. K. PCT Int. Appl. 2006,
WO2006050161. (b) Chen, C.; Webb, T. R.; McCarthy, J. R.;
Moran, T. J. PCT Int. Appl. 1997, WO 9729110. (c) Buchanan, J. G.;
Craven, D. A.; Wightman, R. H.; Harnden, M. R. J. Chem. Soc., Perkin
Trans. 1 1991, 195−202.
(6) (a) Borths, C. J.; Chan, J.; Burke, B. J.; Larson, R. D. Synlett 2009,
19, 3139−3142. (b) Stowell, J. C.; Ham, B. M.; Esslinger, M. A.;
Duplantier, A. J. J. Org. Chem. 1989, 54, 1212−1213. (c) Hartman, G.
D.; Weinstock, L. M. Org. Synth. 1979, 59, 183−186. (d) Mayer, R.;
Berthold, H. Z. Chem. 1963, 3, 310.
(7) (a) Lisowski, V.; Vu, D. N.; Feng, X.; Rault, S. Synthesis 2002,
753−756. (b) Lisowski, V.; Enguehard, C.; Lancelot, J.-C.; Caignard,
D.-H.; Lambel, S.; Leonce, S.; Pierre, A.; Atassi, G.; Renard, P.; Rault,
S. Bioorg. Med. Chem. Lett. 2001, 11, 2205−2208. (c) Dijksman, W. C.;
Verboom, W.; Reinhoudt, D. N.; Hale, C. G.; Harkema, S.; van
Hummel, G. J. Tetrahedron Lett. 1984, 25, 2025−2028.
(8) (a) Hurd, R. N.; DeLaMater, G. Chem. Rev. 1961, 61, 45−86.
(b) Zou, J. P.; Zeng, R. S.; Lu, Z. E.; Chen, K. Q. Trends Heterocycl.
Chem. 2001, 7, 107−116.
(9) Seebach, D.; Lubosch, W.; Enders, D. Chem. Ber. 1976, 109,
1309−1323.
(10) Scott, M. K.; Joacoby, H. I.; Mills, J. E.; Bonfilio, A. C.;
Rasmussen, C. R. J. Med. Chem. 1983, 26, 535−538.
2525
dx.doi.org/10.1021/ol500895t | Org. Lett. 2014, 16, 2522−2525